These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4153531)

  • 21. Stability of cardiac monoamine oxidase activity after chemical sympathectomy with 6-hydroxydopamine.
    Lowe MC; Horita A
    Nature; 1970 Oct; 228(5267):175-6. PubMed ID: 5460020
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective metabolic pathways for noradrena-line in the peripheral and in the central nervous system.
    Langer SZ
    Med Biol; 1974 Dec; 52(6):372-83. PubMed ID: 4374612
    [No Abstract]   [Full Text] [Related]  

  • 23. Biogenic amines in the developing brain.
    Eiduson S
    UCLA Forum Med Sci; 1971; 14():391-418. PubMed ID: 4399509
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuropathy and "middle" molecule toxins.
    Funck-Brentano JL; Man NK; Sausse A; Cueille G; Zinfraff J; Drueke T; Jungers P; Billon JP
    Kidney Int Suppl; 1975 Feb; (3):352-6. PubMed ID: 1057710
    [No Abstract]   [Full Text] [Related]  

  • 25. [Uptake and storage of catecholamines by adrenergic fibers of the central and peripheral nervous system. IV. Synthesis, storage and release of norepinephrine in the adrenergic fibers of the rat iris and vas deferens].
    L'Hermite P
    Arch Anat Microsc Morphol Exp; 1971; 60(4):323-42. PubMed ID: 4403254
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of Arzni carbonate mineral baths on labeled noradrenaline uptake by myocardial sections and the activity of mitochondrial monoamine oxidase].
    Mirzoian SA; Movsesian TG; Karagian AT; Gevorkian GA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1981; (2):42-5. PubMed ID: 6453467
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of tyrosine and phenylalanine deficiency on the monoamine oxidase activity of rat brain].
    Pugge H; Godin Y; Mark J
    J Physiol (Paris); 1969; 61 Suppl 1():163-4. PubMed ID: 5402031
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on the uptake and subcellular distribution of catecholamines and their alpha-methylated analogues.
    Lundborg P
    Acta Physiol Scand Suppl; 1967; 302():1-34. PubMed ID: 5584149
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiac catechol O-methyltransferase and monoamine oxidase activity in congestive heart failure.
    Krakoff LR; Buccino RA; Spann JF; De Champlain J
    Am J Physiol; 1968 Sep; 215(3):549-52. PubMed ID: 4233578
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular geometry and adrenergic drug activity.
    Patil PN; Miller DD; Trendelenburg U
    Pharmacol Rev; 1974 Dec; 26(4):323-92. PubMed ID: 4156804
    [No Abstract]   [Full Text] [Related]  

  • 32. Inverse blood pressure rhythm of transgenic hypertensive TGR(mREN2)27 rats: role of norepinephrine and expression of tyrosine-hydroxylase and reuptake1-transporter.
    Lemmer B; Schiffer S; Witte K; Gorbey S
    Chronobiol Int; 2005; 22(3):473-88. PubMed ID: 16076648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of exercise on several adrenergic system parameters.
    Tarizzo VI; Rubio MC
    Acta Physiol Pharmacol Latinoam; 1984; 34(1):55-63. PubMed ID: 6147951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsomal monoamine oxidase in sympathetically innervated tissues.
    Stjärne L; Roth RJ; Giarman NJ
    Biochem Pharmacol; 1968 Sep; 17(9):2008-12. PubMed ID: 5693934
    [No Abstract]   [Full Text] [Related]  

  • 35. The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart.
    Iversen LL; Glowinski J; Axelrod J
    J Pharmacol Exp Ther; 1965 Nov; 150(2):173-83. PubMed ID: 4379176
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of methylguanidine on norepinephrine metabolism in isolated, perfused spleen and heart.
    Cubeddu L; Mosimann W; Weiner N
    J Pharmacol Exp Ther; 1974 Jan; 188(1):93-106. PubMed ID: 4809281
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on monoamine oxidase of rat heart mitochondria. I. Purification and properties of the enzyme.
    Sen R; Parmar SS; Guha SR
    Acta Biol Med Ger; 1968; 21(1):1-11. PubMed ID: 5724353
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 39. Uptake, retention and metabolism of H 3 -tyramine in rat atria.
    Steinberg MI; Smith CB
    J Pharmacol Exp Ther; 1971 Jan; 176(1):139-48. PubMed ID: 4936457
    [No Abstract]   [Full Text] [Related]  

  • 40. Uraemia suppresses central dopaminergic metabolism and impairs motor activity in rats.
    Adachi N; Lei B; Deshpande G; Seyfried FJ; Shimizu I; Nagaro T; Arai T
    Intensive Care Med; 2001 Oct; 27(10):1655-60. PubMed ID: 11685308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.